Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live

01/03

Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.

The iShares Biotechnology ETF (IBB) was down 0.6%.

In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.

Outlook Therapeutics (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.

Hoth Therapeutics (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2600067611"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2600067611\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2600067611?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-03 02:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2600067611","market":"sg","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Mixed in Afternoon Trading","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was down 0.6%.</p><p>In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.</p><p>Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.</p><p><a href=\"https://laohu8.com/S/HOTH\">Hoth Therapeutics</a> (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Mixed in Afternoon Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Mixed in Afternoon Trading\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-01-03 02:50</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was down 0.6%.</p><p>In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.</p><p>Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.</p><p><a href=\"https://laohu8.com/S/HOTH\">Hoth Therapeutics</a> (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OTLK","symbol_name":"Outlook Therapeutics, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2600067611","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2600067611","pubTimestamp":1767379803,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF  easing 0.1%.The iShares Biotechnology ETF  was down 0.6%.In corporate news, Ironwood Pharmaceuticals  shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.Outlook Therapeutics  shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.Hoth Therapeutics  shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OTLK":"Outlook Therapeutics, Inc.","BK4139":"生物科技","IBB":"生物科技指数ETF-iShares Nasdaq","BK4581":"高盛持仓","LABU":"三倍做多标普生物-Direxion","BK4007":"制药","IRWD":"Ironwood医药","BK4588":"碎股","HOTH":"Hoth Therapeutics","XLV":"健康照护类股ETF-SPDR","BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF"},"translate_title":"行业更新：医疗保健股下午交易涨跌互现","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HOTH":1,"IBB":1,"IRWD":1,"OTLK":1,"XBI":0.6,"XLV":1,"LABU":0.6},"content_text":"Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.The iShares Biotechnology ETF (IBB) was down 0.6%.In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.Outlook Therapeutics (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.Hoth Therapeutics (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}